June McKoy, MD, discusses some of the specific properties of #biosimilars that merit attention in terms of optimizing their safety, and ensuring that appropriate premiums on research are available to ensure ongoing progress in anticancer therapy. https://
Our MFC President, Dr. June McKoy! @NMGeriatrics @NUFeinbergMed @NorthwesternMed @NU_WFO
"Biosimilars: Are They Really Safe?" presented by lead author Dr. Frank Giles and our own Dr. June McKoy. @DrJuneJD https://t.co/zEmnMVQPbP https://t.co/0UamjwdoaA
"Biosimilars: Are They Really Safe?" presented by lead author Dr. Frank Giles and our own Dr. June McKoy. https://t.co/fKvenbjq1D